跳至主要内容
临床试验/NCT02692118
NCT02692118Unknown不适用

Inflammatory Mediators in Sepsis as Indicator for Infection vs Inflammation

University Hospital Tuebingen1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2016年12月最近更新:
适应症

试验速览

阶段
不适用
入组人数
60
试验地点
1
主要终点
Semaphorin 1 to 7 in plasma of septic patients

研究概览

简要总结

Sepsis is still a challenge for clinicians since the detailed pathomechanism are still unknown and until now early markers for sepsis are not defined yet. Immunological pathways and new mediators defined in animal models are not yet investigated in patients with sepsis. Therefore the investigators will measure new mediators in patients with septic shock.

详细描述

Semaphorins 1 to 7 will be determined in Blood of patients with early septic shock. Concentration will be compared with blood concentration of postoperative patients suffering systemic inflammatory response syndrome (SIRS).

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Septic Shock

排除标准

  • Age < 18 > 85
  • no consent of caregiver
  • Trauma patients
  • Burn patients
  • Immunosuppression
  • Pregnancy
  • HIV- hepatitis infection

结局指标

主要结局

Semaphorin 1 to 7 in plasma of septic patients

时间窗: 12 months

Concentration of Semaphorin in plasma of 60 sepsis patients \[pg/ml\].

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Inflammatory Mediators in Early Sepsis | 临床试验